Cathie Wood Sells $15.6 Million of Tempus AI Stock After Merck-Moderna Trial Win, Ark Keeps Selling AMD Shares
benzinga_article·
- Ark Invest executed significant trades on Tuesday, selling 250,062 shares of Tempus AI valued at approximately $15.6 million following the company's stock surge after a successful clinical trial.
- The firm also continued its trend of offloading AMD shares, selling a total of 7,450 shares worth about $3.4 million across two ETFs following AMD's expansion plans in Saudi Arabia.
- Additionally, Ark Invest purchased 504,799 shares of Rocket Lab Corp while reducing its holdings in Twist Bioscience and Shopify.